Fluorescent compounds make tumors glow

VANDERBILT (US)—A series of novel imaging agents could light up tumors as they begin to form—before they turn deadly—and signal their transition to aggressive cancers.


The compounds could have broad applications for detecting tumors earlier, monitoring a tumor’s transition from pre-malignancy to more aggressive growth, and defining tumor margins during surgical removal.